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Hospital Course

Background
•
•
•

Discussion

Contrast-Induced Encephalopathy (CIE) is a rare, reversible
complication of coronary angiography that mimics strokes.
Recent advancements in coronary angiography reduced the
complication rate of diagnostic procedures to less than 1%.
Previous reports of complications focus on arrhythmias, myocardial
infarctions, and ischemic strokes increasing anchoring bias.

• Initial CTA head and neck were negative (figure 3a).
• He was admitted to the cardiology service.
• His HTN resolved with hydralazine 10mg IVx1, magnesium

Figure 1. Diagnostic Coronary Angiography
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1. Left ventriculography: EG >60%.
2. Left Main: Patent with <20% stenosis
3. LAD: Patent stent <50% in-stent restenosis with diffuse 60-70% mid LAD
stenosis. Large first diagonal branch with 50% proximal stenosis.
4. LCx: Nondominant with 1 large OM branch that has diffuse disease with a 70%
proximal stenosis.
5. RCA: Dominant with diffuse atherosclerotic disease with <50% stenosis.

Case Presentation
• HPI: A 76-year-old Caucasian male with DM2, HTN, HLD, and CAD
presented to our ED complaining of acute-onset altered mental status
for 3 hours.
• Cardiac history: One month ago, he had an outpatient workup for
intermittent, substernal chest pain that resolved with rest. Previous
PCI w/ DESx1 in the LAD. Nuclear stress testing showed moderate
probability reversible apico-lateral ischemia prompting coronary
angiography 4 days ago that revealed multivessel CAD (figure 1).
• Family hx: Father: rapidly progressive dementia w/ jaundice
• ROS: Unable to obtain (refused to answer)
• Pertinent Physical Exam Findings:
o T:98.6°F, HR:82bpm, RR:20bpm, BP:187/123(127)mmHg, SpO2:
96% on room air, WT: 121.561 kg
o CV: RRR, no murmurs, no carotid bruits, no JVD
o Neuro: AOx0 and Agitated
• Pertinent Lab Findings:
o Hyperglycemic at 202mg/dL (N:70-110)
o Magnesium of 1.2mg/dL (N:1.8-2.4)
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was repleted, and blood glucose was treated with insulin.
His cognitive status continued to decline and he became
combative requiring restraints.
He developed transient nocturnal fevers up to 102°F.
All studies of urine, blood and CSF were negative.
MRI Brain showed white matter changes (figure 3b).
A TTE for concerns of CVA showed normal systolic function
with trace mitral, tricuspid, and pulmonic regurgitation.
Neurology and Infectious Diseases were consulted to
differentiate acute delirium, heavy metal poisoning, viral
encephalitis, and rubral tremors.
On day 6, he developed dystonic movements concerning for
seizure activity.
Repeat CT Head was negative (figure 3c).
An EEG showed no epileptiform activity.
Daily lab testing was monitored and revealed no abnormalities
throughout his hospital stay.
His confusion and aggressive behavior persisted until day 10,
when he began asking questions and showed signs of being
intermittently lucid.
By day 16, he was persistently lucid with no recollection
of his hospital stay.
After excluding all likely alternatives, CIE was diagnosed.
At a 3-month follow-up, he denied symptom recurrence,
reported medication compliance, and decline further
evaluation for a possible CABG.

Figure 3. Neurological Imaging

Figure 2. Admission ECG

1. Sinus Bradycardia
(51bpm)
2. Junctional Rhythm
3. Left Axis Deviation

3A; Day 1 CT Head
No acute pathology.
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3B; Day 2 MRI Brain
Periventricular white matter
change seen on T2/FLAIR.

3C; Day 10 CT Head
No acute pathology

• This case highlights the importance of maintaining a wide
differential in order to arrive at a diagnosis of exclusion.
• The patient was initially evaluated for a possible stroke with
hypoglycemia quickly ruled out and electrolytes repleted. As
his symptoms persisted despite optimal medical therapy, rarer
etiologies were explored.
• CIE is a rare, self-limiting complication of contrast exposure
with variable symptom onset and duration best studied in
strokes, where hyperosmolar contrast may disrupt the bloodbrain barrier.
• Previous research identifies multiple risk factors for CIE in our
patient, including male gender, hypertension, and a large
volume injection of contrast used for left ventriculography.
• Symptom onset has been reported to begin within a few hours
of exposure, and lasting up to five days.
• Documented radiographic findings in the literature range from
none at all to cortical edema with contrast enhancement of
parenchyma and subarachnoid tissue in CIE following
traditional neurological angiography.
• Additional concerns for etiologies of encephalopathy following
coronary angiography include evaluation for aortic
atherosclerosis and reducing the overall contrast volume
including especially during left ventriculography as our patient
received.
• Treatment focuses on adequate hydration, IV steroids and
anticonvulsants.
• CIE following coronary angiography warrants additional
research regarding disease course, as the prevalence of
cardiovascular disease continues to grow globally.
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